Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 3546 entries
View as:

Integrated Biomarker And Imaging Study - 2

Phase: N/A Priority: Normal
NCT ID: NCT00268996 Org: User:
Start: 11/10/05 End: 08/28/07 Due: 08/28/08

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State

Phase: N/A Priority: Normal
NCT ID: NCT02058576 Org: User:
Start: 02/11/14 End: 01/02/15 Due: 01/02/16

Sb-705498 Rectal Pain Study

Phase: N/A Priority: Normal
NCT ID: NCT00461682 Org: User:
Start: 01/26/07 End: 09/01/07 Due: 09/01/08

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT01686633 Org: User:
Start: 09/20/12 End: 10/15/13 Due: 10/15/14

A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01641692 Org: User:
Start: 05/31/12 End: 02/28/13 Due: 02/28/14

Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00406757 Org: User:
Start: 08/30/06 End: 07/15/09 Due: 07/15/10

To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT03544281 Org: User:
Start: 09/20/18 End: 02/28/24 Due: 02/28/25

Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation

Phase: N/A Priority: Normal
NCT ID: NCT01890447 Org: User:
Start: 01/31/15 End: 02/29/16 Due: 02/28/17

Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

Phase: N/A Priority: Normal
NCT ID: NCT00478621 Org: User:
Start: 05/25/07 End: 10/13/08 Due: 10/13/09

Substance P Challenge in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04676763 Org: User:
Start: 03/02/21 End: 07/21/21 Due: 07/21/22

A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00315731 Org: User:
Start: 03/31/03 End: 06/30/13 Due: 06/30/14

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02105974 Org: User:
Start: 04/07/14 End: 07/08/15 Due: 07/08/16

A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

Phase: N/A Priority: Normal
NCT ID: NCT00858286 Org: User:
Start: 02/28/09 End: 04/30/10 Due: 04/30/11

Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients

Phase: N/A Priority: Normal
NCT ID: NCT00410163 Org: User:
Start: 01/31/07 End: 05/31/13 Due: 05/31/14

A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00453687 Org: User:
Start: 03/09/07 End: 05/16/07 Due: 05/16/08

Fall Epidemic Viral Pediatric Study

Phase: N/A Priority: Normal
NCT ID: NCT01192178 Org: User:
Start: 08/31/10 End: 12/31/10 Due: 12/31/11

REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study

Phase: N/A Priority: Normal
NCT ID: NCT06041386 Org: User:
Start: 03/20/24 End: 06/14/28 Due: 06/14/29

Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT01476046 Org: User:
Start: 03/08/11 End: 06/17/12 Due: 06/17/13

Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT00823719 Org: User:
Start: 05/31/09 End: 09/30/11 Due: 09/30/12

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT00334334 Org: User:
Start: 06/30/06 End: 08/31/07 Due: 08/31/08

A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype

Phase: N/A Priority: Normal
NCT ID: NCT01495494 Org: User:
Start: 11/30/09 End: 11/30/09 Due: 11/30/10

Exploratory Efficacy Study of Guaifenesin in Upper Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01562548 Org: User:
Start: 02/29/12 End: 05/31/13 Due: 05/31/14

Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above

Phase: N/A Priority: Normal
NCT ID: NCT00345904 Org: User:
Start: 07/31/06 End: 08/31/06 Due: 08/31/07

Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00197275 Org: User:
Start: 02/28/06 End: 11/30/06 Due: 11/30/07

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

Phase: N/A Priority: Normal
NCT ID: NCT00502775 Org: User:
Start: 08/31/07 End: 11/30/07 Due: 11/30/08